LNTH,IRWD Stock Price and Quote

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: ABT ISRG BAX ZBH IDXX HOLX DXCM PEN BIO LMAT

| Held by: IJH VTI IWM VB AVUV VBK VXF IWO MDY VTWO

Index	RUT	P/E	28.21	EPS (ttm)	2.38	Insider Own	2.31%	Shs Outstand	66.30M	Perf Week	1.77%
Market Cap	4.45B	Forward P/E	12.08	EPS next Y	5.56	Insider Trans	-81.65%	Shs Float	64.78M	Perf Month	-0.58%
Enterprise Value	4.69B	PEG	-	EPS next Q	1.20	Inst Own	106.28%	Short Float	7.56%	Perf Quarter	31.53%
Income	167.68M	P/S	2.92	EPS this Y	-17.52%	Inst Trans	-11.91%	Short Ratio	4.99	Perf Half Y	19.80%
Sales	1.53B	P/B	3.98	EPS next Y	-0.30%	ROA	7.75%	Short Interest	4.89M	Perf YTD	0.93%
Book/sh	16.88	P/C	11.66	EPS next 5Y	-2.86%	ROE	14.59%	52W High	111.29 -39.64%	Perf Year	-22.71%
Cash/sh	5.76	P/FCF	10.82	EPS past 3/5Y	- 40.75%	ROIC	9.65%	52W Low	47.25 42.16%	Perf 3Y	15.27%
Dividend Est.	-	EV/EBITDA	11.52	Sales past 3/5Y	53.37% 34.59%	Gross Margin	62.23%	Volatility	3.52% 3.24%	Perf 5Y	241.31%
Dividend TTM	-	EV/Sales	3.07	EPS Y/Y TTM	-60.40%	Oper. Margin	22.46%	ATR (14)	2.11	Perf 10Y	3550.54%
Dividend Ex-Date	-	Quick Ratio	2.49	Sales Y/Y TTM	1.95%	Profit Margin	10.99%	RSI (14)	56.45	Recom	1.31
Dividend Gr. 3/5Y	- -	Current Ratio	2.67	EPS Q/Q	-77.13%	SMA20	1.44%	Beta	-0.09	Target Price	81.96
Payout	0.00%	Debt/Eq	0.55	Sales Q/Q	1.39%	SMA50	2.57%	Rel Volume	0.80	Prev Close	65.21
Employees	808	LT Debt/Eq	0.55	Earnings	Nov 06 BMO	SMA200	1.11%	Avg Volume	980.88K	Price	67.17
IPO	Jun 25, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.79% 4.24%	Trades		Volume	784,292	Change	3.01%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-12-25	Upgrade	Truist	Hold → Buy	$80
Oct-08-25	Downgrade	Goldman	Buy → Neutral	$77
Aug-12-25	Downgrade	Truist	Buy → Hold	$63
Dec-18-24	Initiated	Goldman	Buy	$143
Sep-03-24	Initiated	Redburn Atlantic	Buy	$175
Jul-10-24	Reiterated	JMP Securities	Mkt Outperform	$100 → $130
Dec-18-23	Downgrade	William Blair	Outperform → Mkt Perform
Dec-04-23	Initiated	TD Cowen	Outperform	$100
Sep-29-23	Initiated	William Blair	Outperform
Mar-08-23	Initiated	JMP Securities	Mkt Outperform	$120
Nov-30-22	Initiated	SVB Leerink	Outperform
Oct-13-22	Initiated	Mizuho	Buy	$105
May-09-22	Initiated	B. Riley Securities	Buy	$91
Apr-13-22	Initiated	Truist	Buy	$77
Feb-01-21	Initiated	SVB Leerink	Outperform	$24
Jun-29-20	Resumed	Jefferies	Buy	$29
Aug-16-19	Upgrade	CJS Securities	Market Perform → Market Outperform
Nov-02-17	Upgrade	Wells Fargo	Market Perform → Outperform
Nov-08-16	Reiterated	RBC Capital Mkts	Outperform	$6 → $12
Sep-23-16	Resumed	Credit Suisse	Neutral

Show Previous Ratings

Jan-03-26 08:10AM	Lantheus closes SPECT business sale to SHINE Technologies (TipRanks)
Jan-02-26 08:00AM	Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies (GlobeNewswire)
Dec-21-25 10:31PM	Spotting Winners: Lantheus (NASDAQ:LNTH) And Medical Devices & Supplies - Imaging, Diagnostics Stocks In Q3 (StockStory)
Dec-17-25 05:11PM	Truist Sees Upside in Lantheus Holdings, Inc. (LNTH) Despite PYLARIFY Pressure (Insider Monkey)
Dec-12-25 12:45PM	Why Lantheus (LNTH) Stock Is Up Today (StockStory) +5.58%
10:33AM	Loading…
Dec-10-25 10:33AM	Wall Street Remains Bullish On Lantheus Holdings, Inc. (LNTH) (Insider Monkey)
Nov-24-25 08:30AM	Lantheus to Present Florbetaben F 18 Data at CTAD 2025 (GlobeNewswire)
Nov-16-25 11:01PM	Lantheus (LNTH): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
Nov-13-25 12:36AM	5 Insightful Analyst Questions From Lantheus's Q3 Earnings Call (StockStory)
Nov-11-25 03:56PM	Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know (StockStory) +5.29%
Nov-07-25 12:31AM	LNTH Q3 Deep Dive: Leadership Transition and Product Diversification Shape Outlook (StockStory)
Nov-06-25 02:07PM	Lantheus Holdings Inc (LNTH) Q3 2025 Earnings Call Highlights: Navigating Growth Amidst Market ... (GuruFocus.com) -6.19%
07:43AM	Lantheus (NASDAQ:LNTH) Exceeds Q3 Expectations, Stock Soars (StockStory)
07:31AM	Lantheus Holdings: Q3 Earnings Snapshot (Associated Press Finance)
07:02AM	Lantheus Reports Third Quarter 2025 Financial Results and Provides Business Update (GlobeNewswire)
07:00AM	Loading…
07:00AM	Lantheus Announces Leadership Transition Plan (GlobeNewswire)
Nov-04-25 10:12PM	Lantheus (LNTH) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
09:00AM	Lantheus Holdings, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before November 10, 2025 to Discuss Your Rights - LNTH (PR Newswire)
Nov-03-25 03:01AM	Lantheus Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH (PR Newswire)
Oct-30-25 09:49AM	Investors Urged to Contact Levi & Korsinsky for Information Before November 10, 2025 - Lantheus Holdings, Inc. (LNTH) (Newsfile)
08:30AM	Lantheus Announces FDA Grants PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs) (GlobeNewswire)
Oct-29-25 08:28AM	Here's Why Lantheus Holdings (LNTH) Fell in Q3 (Insider Monkey)
Oct-28-25 08:30AM	Lantheus Announces FDA Acceptance of New Drug Application for MK-6240, a PET Imaging Agent Targeting Tau in Alzheimer's Disease (GlobeNewswire)
Oct-23-25 08:30AM	Lantheus to Host Third Quarter 2025 Earnings Conference Call and Webcast on November 6, 2025, at 8:00 a.m. Eastern Time (GlobeNewswire)
08:30AM	Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market (PR Newswire)
Oct-21-25 03:12PM	Shareholders of Lantheus Holdings, Inc. (LNTH): Protect Your Rights Before November 10, 2025 - Contact Levi & Korsinsky (Newsfile)
Oct-17-25 08:45AM	Lantheus Holdings, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - LNTH (PR Newswire)
Oct-13-25 05:03PM	Lantheus Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH (PR Newswire)
09:28AM	Goldman Sachs Downgrades Lantheus (LNTH) PT to $77 Amid PYLARIFY Pricing Pressure, Slow Alzheimer's Drug Uptake (Insider Monkey)
Oct-10-25 09:29AM	Shareholders of Lantheus Holdings, Inc. (LNTH): Protect Your Rights Before November 10, 2025 - Contact Levi & Korsinsky (Newsfile)
07:46AM	Loading…
Oct-07-25 07:46AM	Lantheus Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH (PR Newswire)
Sep-30-25 06:06PM	Lantheus Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH (PR Newswire)
Sep-26-25 09:00AM	Lantheus Holdings, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before November 10, 2025 to Discuss Your Rights - LNTH (PR Newswire)
Sep-24-25 12:05PM	Lantheus (LNTH) Stock Trades Up, Here Is Why (StockStory)
01:00AM	Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY (Piflufolastat F 18) in Japan (GlobeNewswire)
Sep-23-25 10:10AM	Lantheus Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights LNTH (Business Wire)
Sep-19-25 06:33PM	Did you lose money in LNTH? Shareholders Who Incurred Significant Losses in Lantheus Holdings, Inc. Should Contact Robbins LLP for Information (PR Newswire)
Sep-15-25 11:31PM	Q2 Earnings Highs And Lows: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks (StockStory)
Sep-09-25 12:02AM	Lantheus (LNTH): Buy, Sell, or Hold Post Q2 Earnings? (StockStory)
Sep-02-25 08:30AM	Lantheus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference (GlobeNewswire)
04:05AM	FDA Accepts Lantheus Holdings, Inc. (LNTH)' NDA for New PSMA Imaging Agent (Insider Monkey)
Sep-01-25 12:38AM	2 Healthcare Stocks on Our Watchlist and 1 We Avoid (StockStory)
Aug-29-25 12:26AM	Leerink Partners Maintains a Buy on Lantheus Holdings (LNTH) With a $99 PT (Insider Monkey)
Aug-23-25 03:54AM	Lantheus Holdings, Inc. (LNTH) Announces FDA Approval of its New Drug Application for F 18 PSMA Imaging Agent (Insider Monkey)
Aug-13-25 12:16PM	Why Lantheus (LNTH) Stock Is Falling Today (StockStory)
01:34AM	5 Revealing Analyst Questions From Lantheus's Q2 Earnings Call (StockStory)
Aug-12-25 03:45PM	Why Lantheus (LNTH) Stock Is Falling Today (StockStory)
09:40AM	Starbucks upgraded, Shopify downgraded: Wall Street's top analyst calls (The Fly)
03:13AM	LNTH Q2 Deep Dive: Competitive Pressures and Guidance Cut Reshape Lantheus Outlook (StockStory)
Aug-07-25 12:40PM	Lantheus Holdings (LNTH) Dives 28.6% on Tempered Growth Outlook (Insider Monkey) +5.76%
Aug-06-25 01:10PM	Why Lantheus (LNTH) Stock Is Falling Today (StockStory) -28.58%
07:55AM	Lantheus (NASDAQ:LNTH) Reports Sales Below Analyst Estimates In Q2 Earnings, Stock Drops 20.8% (StockStory)
07:27AM	Lantheus Holdings: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Lantheus Reports Second Quarter 2025 Financial Results and Provides Business Update (GlobeNewswire)
06:45AM	Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent (GlobeNewswire)
Aug-05-25 09:31AM	Lantheus Holdings Inc (LNTH) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Aug-04-25 11:21PM	Lantheus (LNTH) Reports Q2: Everything You Need To Know Ahead Of Earnings (StockStory)
Jul-28-25 11:11AM	Riley Reduces Lantheus Holdings (LNTH) PT to $109, Maintains Buy Rating (Insider Monkey)
Jul-27-25 10:01AM	Lantheus Holdings Expands Alzheimer's Diagnostics Despite Recent Stock Dip (Insider Monkey)
Jul-23-25 08:00AM	Lantheus to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025, at 8:00 a.m. Eastern Time (GlobeNewswire)
Jul-22-25 07:00AM	Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D (GlobeNewswire)
Jul-18-25 12:05AM	Lantheus (LNTH): Buy, Sell, or Hold Post Q1 Earnings? (StockStory)
Jul-16-25 12:10PM	Why Lantheus (LNTH) Stock Is Down Today (StockStory) -8.43%
Jul-11-25 03:30PM	Lantheus, ICU Medical, Haemonetics, CONMED, and Astrana Health Shares Plummet, What You Need To Know (StockStory)
Jul-03-25 12:34AM	1 Healthcare Stock to Target This Week and 2 to Be Wary Of (StockStory)
Jul-02-25 01:35AM	Lantheus's Q1 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Jun-29-25 09:56PM	Riley Maintains 'Buy' Rating on Lantheus Holdings, Inc. (LNTH); Lowers PT (Insider Monkey)
Jun-28-25 04:16AM	Lantheus Joins FIBRE Consortium with Pfizer, Lumina to Revolutionize Fibrotic Disease Treatment (Insider Monkey)
Jun-24-25 03:09PM	Lantheus to Present New Oncology Radiodiagnostic Data at SNMMI Meeting (Insider Monkey)
Jun-23-25 11:31PM	Spotting Winners: Lantheus (NASDAQ:LNTH) And Medical Devices & Supplies - Imaging, Diagnostics Stocks In Q1 (StockStory)
Jun-11-25 04:01PM	Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting (GlobeNewswire)
Jun-10-25 08:30AM	Lantheus to Present at the 2025 Truist Securities MedTech Conference (GlobeNewswire)
Jun-03-25 08:30AM	Lantheus to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 (GlobeNewswire)
Jun-02-25 08:00AM	PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer (PR Newswire)
May-14-25 08:30AM	Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn't Ignore (MarketBeat)
May-09-25 10:32AM	Lantheus price target lowered to $120 from $134 at JonesResearch (TipRanks)
May-08-25 06:20AM	Should Invesco S&P MidCap 400 GARP ETF (GRPM) Be on Your Investing Radar? (Zacks)
05:03AM	Why Lantheus Holdings, Inc. (LNTH) Nosedived on Wednesday (Insider Monkey)
03:09AM	Lantheus Holdings Inc (LNTH) Q1 2025 Earnings Call Highlights: Strategic Moves Amidst Mixed ... (GuruFocus.com)
12:49AM	Q1 2025 Lantheus Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
May-07-25 12:01PM	Lantheus Holdings stock drops on lowered full year outlook (Seeking Alpha) -23.23%
11:26AM	Lantheus projects $1.55B-$1.585B revenue for 2025 amid acquisitions and market growth (Seeking Alpha)
11:23AM	Lantheus Holdings, Inc. (LNTH) Q1 2025 Earnings Call Transcript (Seeking Alpha)
07:22AM	Lantheus Holdings: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	Lantheus Reports First Quarter 2025 Financial Results and Provides Business Update (GlobeNewswire)
May-06-25 04:01PM	Lantheus Announces Sale of SPECT Business to SHINE Technologies (GlobeNewswire)
06:20AM	Is Invesco S&P MidCap 400 GARP ETF (GRPM) a Strong ETF Right Now? (Zacks)
Apr-30-25 08:30AM	Lantheus Announces Alzheimer's Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies (GlobeNewswire)
Apr-27-25 03:29PM	Lantheus Holdings, Inc. (LNTH): Among Stocks with Consistent Growth to Buy Now (Insider Monkey)
Apr-23-25 08:30AM	Lantheus to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025, at 8:00 a.m. Eastern Time (GlobeNewswire)
Apr-19-25 05:30AM	ClearBridge Small Cap Strategy Q1 2025 Commentary (Seeking Alpha)
Apr-09-25 12:57PM	3 Biotech Stocks Holding Their Own (Seeking Alpha) +7.23%
Apr-01-25 09:00AM	Lantheus Completes Acquisition of Evergreen Theragnostics (GlobeNewswire)
Mar-27-25 12:03PM	ClearBridge Small Cap Fund Q4 2024 Commentary (SeekingAlpha)
Mar-23-25 12:00PM	Lantheus Holdings: One Blockbuster, Evolving Pipeline (SeekingAlpha)
Mar-20-25 12:00PM	Lazard US Equity Concentrated Portfolio Q4 2024 Commentary (SeekingAlpha)
Mar-14-25 12:10PM	Is Lantheus Holdings, Inc. (LNTH) the Best Healthcare Stock For Long-Term Investment? (Insider Monkey)
Mar-10-25 05:01AM	Q4 Earnings Highs And Lows: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks (StockStory)
Feb-27-25 02:06AM	Lantheus Holdings Inc (LNTH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
Feb-26-25 10:35PM	Q4 2024 Lantheus Holdings Inc Earnings Call (Thomson Reuters StreetEvents) +16.49%

Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Blanchfield Paul	Former Officer	Feb 02 '26	Proposed Sale	66.97	6,713	449,570		Feb 02 01:32 PM
Blanchfield Paul	Former Officer	Jan 06 '26	Proposed Sale	69.53	7,217	501,798		Jan 06 11:43 AM
Blanchfield Paul	Officer	Dec 12 '25	Proposed Sale	66.82	3,265	218,151		Dec 12 03:16 PM
Blanchfield Paul	Former Officer	Nov 26 '25	Proposed Sale	58.31	11,776	686,665		Nov 26 10:43 AM
Blanchfield Paul	Former Officer	Nov 14 '25	Proposed Sale	52.70	16,530	871,106		Nov 14 02:13 PM
PATEL RAJIV A	Member of a Group Owning 10%	Aug 20 '25	Sale	56.15	3,365,000	188,944,750	3,477,227	Aug 21 05:27 PM
PATEL RAJIV A	Member of a Group Owning 10%	Aug 19 '25	Sale	55.34	41,000	2,268,940	6,842,227	Aug 21 05:27 PM
FARALLON PARTNERS L L C/CA	Member of a Group Owning 10%	Aug 20 '25	Sale	56.15	3,365,000	188,944,750	3,477,227	Aug 21 05:27 PM
FARALLON PARTNERS L L C/CA	Member of a Group Owning 10%	Aug 19 '25	Sale	55.34	41,000	2,268,940	6,842,227	Aug 21 05:27 PM
Blanchfield Paul	President	Aug 13 '25	Sale	53.57	3,060	163,924	108,214	Aug 15 04:33 PM
Blanchfield Paul	Officer	Aug 13 '25	Proposed Sale	53.57	3,060	163,924		Aug 13 12:48 PM
Niedzwiecki Daniel	See Remarks	Jun 13 '25	Sale	78.74	6,000	472,440	87,057	Jun 17 04:31 PM
Niedzwiecki Daniel	Officer	Jun 13 '25	Proposed Sale	78.74	6,000	472,440		Jun 13 10:00 AM
McHugh Julie	Director	Jun 09 '25	Sale	81.62	5,192	423,771	25,962	Jun 11 04:33 PM
Marshall Robert J. Jr.	CFO and Treasurer	Jun 09 '25	Option Exercise	49.93	14,773	737,616	128,633	Jun 11 04:32 PM
Marshall Robert J. Jr.	CFO and Treasurer	Jun 09 '25	Sale	83.00	39,773	3,301,296	88,860	Jun 11 04:32 PM
Blanchfield Paul	President	Jun 05 '25	Sale	79.65	6,599	525,610	111,792	Jun 09 04:34 PM
Niedzwiecki Daniel	See Remarks	Jun 05 '25	Sale	79.65	6,000	477,900	93,057	Jun 09 04:34 PM
Marshall Robert J. Jr.	Officer	Jun 09 '25	Proposed Sale	81.62	39,773	3,246,272		Jun 09 11:11 AM
McHugh Julie	Director	Jun 09 '25	Proposed Sale	81.62	5,192	423,771		Jun 09 10:06 AM
Heino Mary Anne	Director	Jun 02 '25	Proposed Sale	76.73	26,066	1,999,957		Jun 05 12:35 PM
Blanchfield Paul	Officer	Jun 05 '25	Proposed Sale	79.65	6,599	525,610		Jun 05 11:23 AM
Niedzwiecki Daniel	Officer	Jun 05 '25	Proposed Sale	79.65	6,000	477,900		Jun 05 10:13 AM
Heino Mary Anne	Director	Jun 02 '25	Sale	76.83	26,066	2,002,570	318,650	Jun 04 04:32 PM
Marshall Robert J. Jr.	CFO and Treasurer	Mar 17 '25	Sale	100.52	10,000	1,005,200	113,860	Mar 19 06:44 PM
Heino Mary Anne	Director	Mar 13 '25	Sale	100.13	2	200	8,618	Mar 17 08:09 PM
Marshall Robert J. Jr.	Officer	Mar 17 '25	Proposed Sale	100.52	10,000	1,005,200		Mar 17 10:49 AM
Blanchfield Paul	President	Mar 05 '25	Sale	98.00	2,084	204,232	91,828	Mar 07 05:44 PM
Heino Mary Anne	Director	Mar 03 '25	Sale	94.35	53,107	5,010,734	440,399	Mar 05 05:09 PM
Blanchfield Paul	Officer	Mar 05 '25	Proposed Sale	98.00	2,084	204,232		Mar 05 10:17 AM
Heino Mary Anne	Officer	Mar 03 '25	Proposed Sale	91.00	53,200	4,841,200		Feb 28 03:31 PM

IRWD Ironwood Pharmaceuticals Inc daily Stock Chart

Peers: ABBV VRTX ALNY GILD INCY NBIX REGN BIIB BMY EXEL

| Held by: IWM FNDA VTI IWO IBB XBI VXF SCHA FESM VTWO

Index	RUT	P/E	29.73	EPS (ttm)	0.15	Insider Own	3.68%	Shs Outstand	162.68M	Perf Week	-4.18%
Market Cap	746.69M	Forward P/E	5.26	EPS next Y	0.87	Insider Trans	-0.90%	Shs Float	156.69M	Perf Month	13.05%
Enterprise Value	1.20B	PEG	-	EPS next Q	-0.07	Inst Own	91.89%	Short Float	6.04%	Perf Quarter	139.06%
Income	29.48M	P/S	2.20	EPS this Y	1066.67%	Inst Trans	1.33%	Short Ratio	2.09	Perf Half Y	448.85%
Sales	338.99M	P/B	-	EPS next Y	648.57%	ROA	7.51%	Short Interest	9.46M	Perf YTD	36.20%
Book/sh	-1.62	P/C	5.32	EPS next 5Y	-	ROE	-	52W High	5.78 -20.59%	Perf Year	159.32%
Cash/sh	0.86	P/FCF	11.04	EPS past 3/5Y	-88.04% -47.49%	ROIC	22.45%	52W Low	0.53 770.80%	Perf 3Y	-58.91%
Dividend Est.	-	EV/EBITDA	8.17	Sales past 3/5Y	-5.30% -3.89%	Gross Margin	99.44%	Volatility	7.12% 7.72%	Perf 5Y	-55.57%
Dividend TTM	-	EV/Sales	3.55	EPS Y/Y TTM	1236.48%	Oper. Margin	42.92%	ATR (14)	0.35	Perf 10Y	-30.50%
Dividend Ex-Date	-	Quick Ratio	1.13	Sales Y/Y TTM	-10.42%	Profit Margin	8.70%	RSI (14)	51.49	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	1.13	EPS Q/Q	906.14%	SMA20	-4.60%	Beta	0.19	Target Price	8.43
Payout	0.00%	Debt/Eq	-	Sales Q/Q	33.26%	SMA50	11.87%	Rel Volume	0.69	Prev Close	4.84
Employees	253	LT Debt/Eq	-	Earnings	Nov 10 BMO	SMA200	135.24%	Avg Volume	4.52M	Price	4.59
IPO	Feb 03, 2010	Option/Short	Yes / Yes	EPS/Sales Surpr.	117.60% 63.38%	Trades		Volume	3,125,663	Change	-5.17%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-05-26	Upgrade	Citizens JMP	Mkt Perform → Mkt Outperform	$8
Apr-15-25	Downgrade	Wells Fargo	Overweight → Equal Weight
Apr-15-25	Downgrade	Jefferies	Buy → Hold
Apr-14-25	Downgrade	Citizens JMP	Mkt Outperform → Mkt Perform
Sep-09-24	Initiated	Leerink Partners	Market Perform	$5
Aug-08-24	Downgrade	CapitalOne	Overweight → Equal Weight	$12 → $4
Jan-17-24	Initiated	Craig Hallum	Buy	$21
Dec-14-23	Initiated	Wells Fargo	Overweight	$20
Nov-09-23	Initiated	Jefferies	Buy	$21
Sep-28-23	Initiated	JMP Securities	Mkt Outperform	$22
Sep-02-22	Initiated	CapitalOne	Overweight	$15
Apr-22-22	Initiated	Piper Sandler	Overweight	$16
Sep-30-20	Downgrade	Wells Fargo	Overweight → Equal Weight	$14 → $9
Jun-17-20	Initiated	Northland Capital	Outperform	$14
Jul-10-19	Resumed	Credit Suisse	Neutral
Mar-27-19	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Feb-25-19	Upgrade	H.C. Wainwright	Sell → Neutral	$14
Jan-24-19	Upgrade	JP Morgan	Underweight → Neutral
Nov-07-18	Downgrade	JP Morgan	Neutral → Underweight
Nov-07-18	Downgrade	Credit Suisse	Outperform → Neutral

Show Previous Ratings

Feb-08-26 08:28AM	3 Stocks Trading Near $5 With Massive Earnings Upside (MarketBeat)
Feb-05-26 08:48AM	Does Ironwood's Bullish 2026 View Signal Greater Linzess Adoption? (Zacks)
Feb-04-26 09:06AM	Craig-Hallum Bullish on Ironwood Pharmaceuticals (IRWD), Keeps Buy Rating (Insider Monkey) -6.37%
Jan-26-26 02:11AM	Zacks.com featured highlights include IPG Photonics, Ironwood and Science Applications (Zacks)
Jan-23-26 10:33AM	4 Stocks Trading Near 52-Week High With More Upside Potential (Zacks)
09:36AM	Loading…
Jan-08-26 09:36AM	Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics (Zacks)
Jan-07-26 03:25PM	Ironwood Pharmaceuticals' 2026 Guidance Shock Sparks a Major Re-Rating (MarketBeat) -5.12%
08:45AM	5 Small Drug Stocks to Buy as Industry Recovery Picks Up (Zacks)
Jan-05-26 10:28AM	Ironwood Stock Rises 27% on Upbeat Revenue Guidance for 2026 (Zacks) +7.49%
Jan-03-26 07:20AM	Ironwood backs FY25 revenue view $290M-$310M, consensus $306.97M (TipRanks)
07:20AM	Ironwood sees FY26 revenue $450M-$475M, consensus $319.47M (TipRanks)
Jan-02-26 12:21PM	Ironwood Pharmaceuticals Stock Soars as Drug-Price Cut Boosts Prospects for 2026 (Barrons.com) +26.71%
07:05AM	Ironwood Pharmaceuticals Maintains FY 2025 Financial Guidance and Announces FY 2026 Financial Guidance (Business Wire)
Dec-10-25 11:30AM	Why Is Ironwood (IRWD) Up 24.9% Since Last Earnings Report? (Zacks)
Nov-28-25 10:11AM	Ironwood (IRWD) Skyrockets 23% as Govt Price for Linzess Falls Within Expectations (Insider Monkey) -9.33%
11:58AM	Loading…
Nov-27-25 11:58AM	IRWD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Pick? (Zacks)
Nov-21-25 10:30AM	Can Linzess Continue to Aid IRWD's Top Line After a Strong Q3? (Zacks)
Nov-13-25 10:36AM	IRWD Rises 110% in a Month: Should You Buy, Sell or Hold the Stock? (Zacks) +8.36%
Nov-11-25 09:56AM	IRWD Beats on Q3 Earnings & Revenues, Raises 2025 View, Stock Soars (Zacks) +14.23%
Nov-10-25 08:25AM	Ironwood Pharmaceuticals (IRWD) Q3 Earnings and Revenues Surpass Estimates (Zacks) +31.77%
07:21AM	Ironwood: Q3 Earnings Snapshot (Associated Press Finance)
07:05AM	Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance (Business Wire)
Nov-06-25 07:35AM	Former blockbuster Linzess grows label with paediatric IBS-C approval (Pharmaceutical Technology)
Nov-05-25 05:35PM	Xencor (XNCR) Reports Q3 Loss, Misses Revenue Estimates (Zacks) +10.16%
Oct-20-25 09:15AM	Xeris Biopharma Holdings, Inc. (XERS) Hit a 52 Week High, Can the Run Continue? (Zacks) +7.69%
Oct-16-25 07:56AM	BioCryst (BCRX) Soars 6.1%: Is Further Upside Left in the Stock? (Zacks)
Oct-15-25 09:17AM	Teladoc Health Expands Clarity Platform With Workplace Safety Tool (Zacks) +8.78%
06:19AM	Zacks Industry Outlook Highlights Akebia Therapeutics, Ironwood Pharmaceuticals, Pyxis Oncology, Cardiol Therapeutics and Plus Therapeutics (Zacks)
Oct-14-25 10:57AM	5 Small Drug Stocks to Buy as the Industry Shows Some Recovery (Zacks)
09:50AM	Why Ironwood Pharmaceuticals (IRWD) is a Top Momentum Stock for the Long-Term (Zacks)
09:50AM	Loading…
Sep-22-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Aug-21-25 09:50AM	Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio (Zacks) +7.27%
Aug-08-25 10:36AM	IRWD Stock Rises as Q2 Earnings & Revenues Trump Estimates (Zacks)
Aug-07-25 08:25AM	Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue Estimates (Zacks) +9.32%
07:26AM	Ironwood: Q2 Earnings Snapshot (Associated Press Finance)
07:05AM	Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance (Business Wire)
Jun-06-25 11:31AM	Why Is Ironwood (IRWD) Down 18.4% Since Last Earnings Report? (Zacks) +6.58%
May-08-25 09:55AM	IRWD Stock Down 15% as Q1 Earnings & Revenues Miss Estimates (Zacks) -11.63%
May-07-25 08:20AM	Ironwood Pharmaceuticals (IRWD) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -14.55%
07:26AM	Ironwood: Q1 Earnings Snapshot (Associated Press Finance)
07:05AM	Ironwood Pharmaceuticals Reports First Quarter 2025 Results (Business Wire)
May-06-25 10:00AM	Vivos Therapeutics, Inc. (VVOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release (Zacks)
May-05-25 07:15AM	Recursion Pharmaceuticals (RXRX) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
May-03-25 10:24PM	The 1-Minute Market Report May 4, 2025 (Seeking Alpha)
May-01-25 10:01AM	Analysts Estimate Ironwood Pharmaceuticals (IRWD) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-30-25 04:25PM	Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference (Business Wire)
Apr-28-25 10:25AM	The 1-Minute Market Report April 27, 2025 (Seeking Alpha) +9.23%
Apr-25-25 07:05AM	Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance (Business Wire)
Apr-22-25 04:05PM	Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support (Business Wire) +7.66%
Apr-16-25 01:07PM	Biotech Stock Roundup: BMY Down on Study Failure, VERV Up on Study Data & More News (Zacks)
Apr-15-25 09:18AM	Ironwood Shares Tank on Regulatory Update for Apraglutide (Zacks) +11.47%
07:12AM	Ironwoods shares sink as FDA demands new trial for lead drug (Pharmaceutical Technology)
Apr-14-25 07:00AM	Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide (Business Wire) -31.48%
Apr-13-25 10:44AM	The 1-Minute Market Report April 13, 2025 (Seeking Alpha)
Apr-10-25 10:49AM	Ironwood Pharmaceuticals: Setting A Strong Foundation For A Return To Growth (Seeking Alpha)
09:25AM	Why Ironwood Pharmaceuticals Inc. (IRWD) Went Down On Thursday? (Insider Monkey)
Apr-01-25 10:28AM	Corcept (CORT) Stock Jumps 109.1%: Will It Continue to Soar? (Zacks)
Mar-31-25 08:05AM	The 1-Minute Market Report March 30, 2025 (Seeking Alpha)
Mar-27-25 04:05PM	Ironwood Pharmaceuticals Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2024 Form 10-K Filing (Business Wire)
Mar-25-25 11:08AM	Catalyst (CPRX) Surges 6.2%: Is This an Indication of Further Gains? (Zacks)
Mar-02-25 12:24PM	Is Ironwood Pharmaceuticals, Inc. (IRWD) the Best Small Cap Pharma Stock to Buy Now? (Insider Monkey)
Feb-28-25 02:14AM	Ironwood Pharmaceuticals Inc (IRWD) Q4 2024 Earnings Call Highlights: Strong Prescription ... (GuruFocus.com)
Feb-27-25 11:20PM	Q4 2024 Ironwood Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) -5.26%
08:15AM	Ironwood Pharmaceuticals (IRWD) Q4 Earnings and Revenues Miss Estimates (Zacks)
07:20AM	Ironwood: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance (Business Wire)
Feb-26-25 08:13AM	Ironwood Pharmaceuticals Inc (IRWD) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Feb-20-25 04:00PM	Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call (Business Wire)
Feb-05-25 06:28PM	Millrose Properties Set to Join S&P SmallCap 600 (PR Newswire) -8.06%
Jan-29-25 04:05PM	Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future (Business Wire) -38.17%
Jan-18-25 08:20AM	Ozempic, Xtandi among next 15 drugs selected for U.S. price talks (TipRanks)
Dec-20-24 09:15AM	Heres Why Brown Capital Management Small Company Fund Sold Ironwood Pharmaceuticals (IRWD) (Insider Monkey) +14.69%
Nov-26-24 04:01PM	Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference (Business Wire) +5.07%
Nov-13-24 04:01PM	Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference (Business Wire)
Nov-08-24 04:01AM	Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ... (GuruFocus.com) +6.44%
Nov-07-24 08:15AM	Ironwood Pharmaceuticals (IRWD) Misses Q3 Earnings Estimates (Zacks) -7.54%
07:20AM	Ironwood: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Ironwood Pharmaceuticals Reports Third Quarter 2024 Results (Business Wire)
Nov-06-24 07:29AM	Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Report Preview: What To Expect (GuruFocus.com) +12.25%
Oct-28-24 07:00AM	Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024 (Business Wire)
Oct-24-24 04:00PM	Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call (Business Wire)
Oct-16-24 01:06PM	State Street Corp's Strategic Acquisition of Ironwood Pharmaceuticals Shares (GuruFocus.com)
08:58AM	Is Ironwood Pharmaceuticals, Inc. (IRWD) the Penny Stock with the Biggest Upside Potential According to Analysts? (Insider Monkey)
Oct-09-24 05:36PM	Ironwood Pharmaceuticals Inc (IRWD) Q2 2024 Earnings Call Highlights: Strong LINZESS Demand ... (GuruFocus.com)
Sep-17-24 08:40AM	Implied Volatility Surging for Ironwood (IRWD) Stock Options (Zacks)
Sep-01-24 10:26PM	Ironwood Pharmaceuticals, Inc. (IRWD): The Best Multibagger Penny Stock of 2025? (Insider Monkey)
Aug-29-24 08:41PM	10 Best Multibagger Penny Stocks of 2025 (Insider Monkey) +7.58%
04:01PM	Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference (Business Wire)
Aug-09-24 10:56AM	Ironwood (IRWD) Q2 Earnings & Revenues Fall Shy of Estimates (Zacks)
Aug-08-24 08:15AM	Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q2 (Zacks) -32.61%
07:16AM	Ironwood: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Ironwood Pharmaceuticals Reports Second Quarter 2024 Results (Business Wire)
Aug-01-24 10:01AM	Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q2 Earnings Expected to Decline (Zacks)
Jul-25-24 04:00PM	Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call (Business Wire)
Jul-17-24 08:30AM	Implied Volatility Surging for Ironwood Pharmaceuticals (IRWD) Stock Options (Zacks)
Jul-08-24 07:00AM	Memo Therapeutics AG appoints Paul Carter as Chairperson (GlobeNewswire)
Jun-12-24 07:00PM	Insider Sale: Director Julie Mchugh Sells Shares of Ironwood Pharmaceuticals Inc (IRWD) (GuruFocus.com) -6.27%
Jun-10-24 07:00PM	Insider Sale: Director Catherine Moukheibir Sells 80,000 Shares of Ironwood Pharmaceuticals Inc ... (GuruFocus.com)
May-30-24 04:01PM	Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference (Business Wire)
May-21-24 06:00AM	Ironwood Late-Breaker Oral Presentation at Digestive Disease Week Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF) (Business Wire) +5.61%

Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Silver Ronald	Principal Accounting Officer	Jan 05 '26	Sale	4.60	35,416	162,914	276,809	Jan 07 04:05 PM
RONALD SILVER	Officer	Jan 05 '26	Proposed Sale	4.27	35,416	151,226		Jan 05 04:41 PM
Gaskins Tammi L	Chief Commercial Officer	Nov 17 '25	Sale	3.32	6,016	19,973	235,264	Nov 19 04:05 PM
Gaskins Tammi L	Officer	Nov 17 '25	Proposed Sale	3.37	6,324	21,312		Nov 14 04:05 PM
Gaskins Tammi L	Chief Commercial Officer	Aug 11 '25	Sale	0.84	1,316	1,105	241,280	Aug 13 04:05 PM
John Minardo	Chief Legal Officer	Aug 11 '25	Sale	0.84	7,754	6,513	400,378	Aug 13 04:05 PM
Martini Gregory S.	Chief Financial Officer	Aug 11 '25	Sale	0.84	1,265	1,063	182,545	Aug 13 04:05 PM
Silver Ronald	Principal Accounting Officer	Aug 11 '25	Sale	0.84	2,846	2,391	276,809	Aug 13 04:05 PM
John Minardo	Officer	Aug 11 '25	Proposed Sale	0.88	8,281	7,287		Aug 08 04:10 PM
Martini Gregory S.	Officer	Aug 11 '25	Proposed Sale	0.88	1,351	1,189		Aug 08 04:09 PM
Gaskins Tammi L	Officer	Aug 11 '25	Proposed Sale	0.88	1,406	1,237		Aug 08 04:08 PM
MCCOURT Thomas A	Chief Executive Officer	May 16 '25	Sale	0.58	13,353	7,745	1,147,281	May 20 04:14 PM
Gaskins Tammi L	Chief Commercial Officer	May 16 '25	Sale	0.58	2,563	1,487	242,596	May 20 04:10 PM
MCCOURT Thomas A	Officer	May 19 '25	Proposed Sale	0.59	14,661	8,650		May 16 04:07 PM
Gaskins Tammi L	Officer	May 19 '25	Proposed Sale	0.59	2,814	1,660		May 16 04:05 PM

LNTH

Lantheus Holdings Inc

IRWD

Ironwood Pharmaceuticals Inc

Upgrade your FINVIZ experience